{"id":"https://openalex.org/A5120129992","orcid":"https://orcid.org/0009-0008-2257-5549","observed_orcids":["https://orcid.org/0009-0008-2257-5549"],"display_name":"Maximiliano D\u00e1valos","raw_author_names":["Maximiliano Davalos Munoz","Maximiliano D\u00e1valos","Maximiliano D\u00e1valos Mu\u00f1oz"],"full_name":"Maximiliano D\u00e1valos","works_count":5,"cited_by_count":0,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":0,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5120129992","orcid":"https://orcid.org/0009-0008-2257-5549","observed_orcids":["https://orcid.org/0009-0008-2257-5549"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4405255779","ror":"https://ror.org/03dsae014","display_name":"Hospital Cl\u00ednico F\u00e9lix Bulnes","country_code":"CL","type":"healthcare","lineage":["https://openalex.org/I4405255779"]},"years":[2026,2025]}],"last_known_institutions":[{"id":"https://openalex.org/I4405255779","ror":"https://ror.org/03dsae014","display_name":"Hospital Cl\u00ednico F\u00e9lix Bulnes","country_code":"CL","type":"healthcare","lineage":["https://openalex.org/I4405255779"]}],"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","count":4,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","count":4,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","count":1,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","count":1,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","count":1,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","value":2.04e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","value":8.3e-06,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","value":8.1e-06,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","value":3.9e-06,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10697","display_name":"Vasculitis and related conditions","value":3.4e-06,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.9172999858856201},{"id":"177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","score":0.597100019454956},{"id":"2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","score":0.5641999840736389},{"id":"203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","score":0.546500027179718},{"id":"2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","score":0.35929998755455017}],"counts_by_year":[{"year":2025,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2026,"works_count":4,"oa_works_count":1,"cited_by_count":0}],"display_name_alternatives":["Maximiliano Davalos Munoz","Maximiliano D\u00e1valos","Maximiliano D\u00e1valos Mu\u00f1oz"],"block_key":"m davalos","works_api_url":"https://api.openalex.org/works?filter=author.id:A5120129992","awards_count":0,"updated_date":"2026-11-05T13:29:08","created_date":"2025-10-25T00:00:00"}